Atlas Trials

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Clinical trial NCT05170594 · UNKNOWN

Trial details

NCT number
NCT05170594
Sponsor
The Second Affiliated Hospital of Shandong First Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-12-24
Primary completion
2024-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.